Our congratulations to Dirk Heckl, who has now officially joined the faculty of the Universitätsklinikum Halle as professor of Experimental Pediatrics, after more than a year apart.
Two of our papers went online this week! 1) Identification and validation of molecular events that drive progression from transient abnormal myelopoiesis to full-blown Down syndrome myeloid leukemia.
Two of our papers went online this week! 2) A review article on the regulatory roles of long noncoding acute myeloid leukemia, including an updated catalog of functionally characterized examples.
Another excellent PhD defense this year! Congratulations to Dr. rer. nat. Sofia Gialesaki, who graduated with a summa cum laude in June - among the first from the PhD program's entering class of 2015!
We are very proud of Sofia, who won a YoungEHA Best Abstract Award and presented the RUNX1 story to thousands during the EHA 2019 Presidential Symposium today. Yay Sofia!
Following an excellent thesis defense, Dr. rer. nat. Maurice Labuhn graduated with a summa cum laude from the HBRS Molecular Medicine PhD program. Many congratulations!
The TMD Prevention 2007 trial found that low-dose cytarabine treatment reduced mortality in TMD patients. However, this therapy did not prevent disease progression to ML-DS.
We have an open position for a skilled and dedicated postdoc in our new laboratory in Halle. Applications are welcome until the end of February. See the full post for more details.
The proceeds from this year's Charity Day were given to Pediatrics I of the Universitätsklinikum Halle. The funds will support research on leukemia in children with Down sydrome.
CRISPR-Cas9 genome editing was used to induce GATA1s in HSPCs of fetal, neonatal, and adult origin, leading to distinct ontogeny-specific disturbances in megakaryopoiesis and erythropoiesis.